Comparison of infection risk between enzalutamide and abiraterone in patients with prostate cancer.

Autor: Lee YHA; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China., Chan JSK; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China., Leung CH; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China., Liu AQ; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Ng K; Department of Medical Oncology, Barts Cancer Centre, London, UK., Shamash J; Department of Medical Oncology, Barts Cancer Centre, London, UK., Tse G; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China.; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Kent and Medway Medical School, Canterbury, Kent, UK.; School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, China., Wai Leung DK; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China., Ng CF; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.; SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.

Publikováno v: Cancer [Cancer] 2024 Nov 15; Vol. 130 (22), pp. 3826-3835. Date of Electronic Publication: 2024 Jul 21.

Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study.

Autor: Lee YHA; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China.; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China., Hui JMH; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China., Leung CH; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China., Tsang CTW; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China., Hui K; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China., Tang P; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China., Chan JSK; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, China., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ng K; Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK., McBride S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Nguyen PL; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA, USA., Tse G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, China. gary.tse@kmms.ac.uk.; Kent and Medway Medical School, Canterbury, Kent, CT2 7NT, UK. gary.tse@kmms.ac.uk.; School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, China. gary.tse@kmms.ac.uk., Ng CF; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. ngcf@surgery.cuhk.edu.hk.; SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China. ngcf@surgery.cuhk.edu.hk.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Dec; Vol. 27 (4), pp. 776-782. Date of Electronic Publication: 2023 Dec 05.

Cardiovascular health of patients with cancer: Challenges abound.

Autor: Chan JSK; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, PR China., Chan RNC; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, PR China., Lee YHA; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, PR China; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, PR China; SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, PR China., Satti DI; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, PR China; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ng K; Department of Medical Oncology, Barts Cancer Centre, London, UK., Achim A; Department of Internal Medicine, Invasive Cardiology Division, University of Szeged, Szeged, Hungary; Department of Cardiology, 'Niculae Stancioiu' Heart Institute, University of Medicine and Pharmacy 'Iuliu Hatieganu', Cluj-Napoca, Romania., Ng CF; Division of Urology, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, PR China; SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, PR China., Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, PR China., Matthews GDK; Norwich Medical School, University of East Anglia, Norwich Research Park, Rosalind Franklin Road, Norwich, UK; Department of Cardiology, Norfolk and Norwich University NHS Foundation Trust, Colney Lane, Norwich, UK., Tse G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, PR China; Kent and Medway Medical School, Canterbury, Kent CT2 7NT, UK; School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, PR China. Electronic address: gary.tse@kmms.ac.uk., Vassiliou VS; Norwich Medical School, University of East Anglia, Norwich Research Park, Rosalind Franklin Road, Norwich, UK; Department of Cardiology, Norfolk and Norwich University NHS Foundation Trust, Colney Lane, Norwich, UK.

Publikováno v: Trends in cardiovascular medicine [Trends Cardiovasc Med] 2024 Apr 22. Date of Electronic Publication: 2024 Apr 22.

The modified Rajan's heart failure risk score predicts all-cause mortality in patients hospitalized for heart failure with reduced ejection fraction: a retrospective cohort study.

Autor: Rajan R; Department of Cardiology, Sabah Al Ahmad Cardiac Center, Kuwait City, Kuwait., Hui JMH; Heart Failure and Structural Heart Disease Unit, Cardiovascular Analytics Group, Hong Kong, China-United Kingdom collaboration.; Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Al Jarallah MA; Department of Cardiology, Sabah Al Ahmad Cardiac Center, Kuwait City, Kuwait., Tse G; Heart Failure and Structural Heart Disease Unit, Cardiovascular Analytics Group, Hong Kong, China-United Kingdom collaboration., Chan JSK; Heart Failure and Structural Heart Disease Unit, Cardiovascular Analytics Group, Hong Kong, China-United Kingdom collaboration., Satti DI; Heart Failure and Structural Heart Disease Unit, Cardiovascular Analytics Group, Hong Kong, China-United Kingdom collaboration., Hui CTC; Heart Failure and Structural Heart Disease Unit, Cardiovascular Analytics Group, Hong Kong, China-United Kingdom collaboration.; Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong., Sun Y; Heart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China., Lee YHA; Heart Failure and Structural Heart Disease Unit, Cardiovascular Analytics Group, Hong Kong, China-United Kingdom collaboration., Liu Y; Heart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China., Vijayaraghavan G; Department of Cardiology, Kerala Institute of Medical Sciences, Kerala, India., Al-Zakwani I; Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman & Gulf Health Research, Muscat, Oman., AlObaid L; Department of Medicine, Faculty of Medicine, Royal College of Surgeons, Dublin, Ireland.

Publikováno v: Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2024 Feb 28; Vol. 86 (4), pp. 1843-1849. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).

Associations Between Social Determinants of Health and Cardiovascular Health of U.S. Adult Cancer Survivors.

Autor: Satti DI; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Limited, Hong Kong SAR.; Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Chan JSK; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Limited, Hong Kong SAR., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Lee YHA; Cardio-Oncology Research Unit, Cardiovascular Analytics Group, PowerHealth Limited, Hong Kong SAR., Wai AKC; Emergency Medicine Unit, Faculty of Medicine, The University of Hong Kong, Hong Kong SAR., Dani SS; Division of Cardiovascular Medicine, Comparative Effective Research Institute, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA., Virani SS; Aga Khan University, Karachi, Pakistan.; Texas Heart Institute, Baylor College of Medicine, Houston, Texas, USA., Shapiro MD; Center for Prevention of Cardiovascular Disease, Section on Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Sharma G; Inova Heart and Vascular Institute, Inova Fairfax Medical Campus, Falls Church, Virginia, USA., Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China., Tse G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong SAR.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2023 Oct 24; Vol. 6 (3), pp. 439-450. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2024).